Huinno
휴이노 메모 오피셜 웹사이트
Seoul, South Korea · Founded 2015 · $59.5M raised
- Headquarters
- Seoul
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B2C
- Website
- www.huinno.com
- Total Funding
- $59.5M
- Last Round
- $36.5M Series CDec 2024
- Rounds
- 4
About
Huinno is an AI-driven digital healthcare company developing wearable ECG monitoring devices and cloud-based cardiac disease management platforms. Its MEMO product line includes wearable ECG patches and AI-powered arrhythmia detection software (ECG-GraphNet), which ranked 1st globally in the PhysioNet AI Challenge 2021. The company holds US FDA clearance for its wearable ECG device.
Summary
Huinno is a Healthcare company based in Seoul, South Korea, founded in 2015. It has raised $59.5M in total across 4 rounds, most recently a $36.5M Series C round in Dec 2024. Investors include Meritz Securities, DAOL Investment and Samsung Venture Investment Corporation.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe